Why the Wesfarmers (ASX:WES) share price has underperformed the ASX 200 in the last 3 months

The company's shares are on the comeback of late…

| More on:
A female Woolworths customer leans on her shopping trolley as she rests her chin in her hand thinking about what to buy for dinner while also wondering why the Woolworths share price isn't doing as well as Coles recently

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Wesfarmers Ltd (ASX: WES) share price has managed to shoot higher recently after hitting a 6-month low last month. The company's shares touched the bottom at $53.83 on 11 October before zipping upwards.

However, when looking at the past 3 months, the conglomerate's shares have lost around 8.6%. By compassion, the S&P/ASX 200 Index (ASX: XJO) has fallen 1.7% over the same time frame.

Below, we take a closer look at what's been happening with the Wesfarmers share price.

What's troubling Wesfarmers shares?

Investors have been mixed on the Wesfarmers share price as the company continues to navigate its way through COVID-19.

Wesfarmers released the notes from its annual general meeting (AGM) last month, holding back on providing a new trading update.

The company reported very similar commentary to how it performed over the FY21 period

In particular, it stated that some of its businesses, such as Bunnings, K-mart and Target, were impacted by store closures. Although, it said strong online sales managed to offset the loss of potential revenue.

On the other hand, Officeworks thrived as customer demand for technology and office furniture accelerated. This was attributed to more people working from home due to government-mandated restrictions.

The Wesfarmers chemicals, energy and fertilisers division continued to grow on the back of ammonium nitrate and favourable LPG pricing.

The company has progressed its proposal on acquiring Australian Pharmaceutical Industries Ltd (ASX: API). An all-cash proposal of $1.55 per share was made to buy up the remaining interest in the pharmaceutical chain operator.

Wesfarmers recently upped its stake in Australian Pharmaceutical Industries to a 19.3% interest.

Are Wesfarmers shares a buy?

A number of brokers note weighed in on the company's shares following the release of its AGM.

Swiss global investment bank Credit Suisse raised its price target on Wesfarmers shares by 0.8% to $60.38. Following suit, Jarden also lifted its outlook by 1% to $60.60 apiece.

While this is slightly above the current Wesfarmers share price of $60.09 at the time of writing, analysts at Citi had a different view.

The firm retained its "sell" rating and put a bearish $50.00 price target on the conglomerate's shares.

Investors appear to be somewhere around the middle ground between Credit Suisse and Citi's estimates.

Wesfarmers share price review

In 2021, the Wesfarmers share price has gained 19%, surging past pre-pandemic levels and making new record highs.

Wesfarmers commands a market capitalisation of around $68 billion, making it the 8th largest company on the ASX.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Consumer Staples & Discretionary Shares

A delivery man carries a basket of food into an apartment
Consumer Staples & Discretionary Shares

Guzman Y Gomez shares push higher on Uber deal

The taco seller is strengthening its delivery business with an exclusive partnership.

Read more »

Happy couple doing grocery shopping together.
Consumer Staples & Discretionary Shares

At $31, are Woolworths shares still a slam-dunk buy?

After a difficult year, earnings are stabilising and confidence is slowly returning.

Read more »

A woman in a red dress holding up a red graph.
Consumer Staples & Discretionary Shares

As reporting season looms, where will the market head next and what should you be buying?

Check out what the experts are saying.

Read more »

Casino players throwing chips in the air.
Consumer Staples & Discretionary Shares

Is it still game on for Light & Wonder shares?

The rally may have stalled, but brokers still see some upside for the ASX gaming stock.

Read more »

Woman chooses vegetables for dinner, smiling and looking at camera.
Consumer Staples & Discretionary Shares

Why Goldman Sachs expects Woolworths shares to leap 21%, plus dividends!

Goldman Sachs has a buy rating on Woolworths' resurgent shares. Let’s see why.

Read more »

A baby's eyes open wide in surprise as it sucks on a milk bottle.
Consumer Staples & Discretionary Shares

Chinese birthrate punches a hole in the A2 Milk share price

This key market is looking challenging.

Read more »

a man frustrated looking at the engine of his car
Consumer Staples & Discretionary Shares

ARB shares are crashing 15% today. What's spooking investors?

ARB shares slide 15% after a profit downgrade rattles investors.

Read more »

Woman and 2 men conducting a wine tasting.
Consumer Staples & Discretionary Shares

Can this ASX 200 stock recover after losing 51%?

Broker enthusiasm is going flat for the prestigious wine share.

Read more »